Clinical Site Services

We operate a dedicated clinical research site supporting early- and mid-phase clinical trials across multiple therapeutic areas. Our site is designed for efficient, compliant execution of Phase I–II studies, including pharmacokinetic (PK), pharmacodynamic (PD), and drug–drug interaction (DDI) studies.

With experienced investigators, trained study staff, and established operational processes, we provide reliable site-level execution while working seamlessly with sponsors and CRO partners.

• Early-phase, PK, PD, DDI, and focused specialty studies 
• Healthy volunteers and patient populations (protocol-dependent)  
• Blood & urine collection, processing, aliquoting, chain-of-custody 
• Safety monitoring and source documentation 
• IRB-compliant informed consent and regulatory processes
• Dedicated clinical research space, phlebotomy and processing areas
• Temperature-monitored refrigeration, emergency preparedness equipment 
• IRB submissions, GCP-compliant documentation, inspection readiness
• SOP-driven processes, training documentation, audit support 

• ICH GCP–aligned operations 
• IRB-approved procedures and documentation 
• Inspection-ready regulatory files 
• Study-specific staff training and oversight
   

Wakefield Clinical Research provides both CRO and clinical trial site services. When both services are involved in a study, roles and responsibilities are clearly defined to ensure regulatory compliance, operational transparency, and adherence to Good Clinical Practice.